[ACRX] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
05-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 37.03%
YoY- -28.01%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 3,366 15,428 4,825 548 166 408 0 -
PBT -11,438 5,841 671 -10,986 -8,582 -5,761 -3,404 22.36%
Tax -36 772 6,556 -1,980 390 356 996 -
NP -11,402 5,069 671 -10,986 -8,582 -5,761 -3,601 21.15%
Tax Rate - -13.22% -977.05% - - - - -
Total Cost 14,768 10,359 4,154 11,534 8,748 6,169 3,601 26.49%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin -338.74 32.86 13.91 -2,004.74 -5,169.88 -1,412.01 0.00 -
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS -5.03 2.20 0.40 -5.30 -7.58 -5.92 -107.66 -39.95%
EPS Diluted -5.03 2.20 -2.60 -5.30 -7.58 -5.92 -107.66 -39.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.